135 related articles for article (PubMed ID: 16304261)
1. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD.
Kanazawa H; Yoshikawa J
Chest; 2005 Nov; 128(5):3191-7. PubMed ID: 16304261
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease.
Kanazawa H; Shiraishi S; Hirata K; Yoshikawa J
Thorax; 2003 Feb; 58(2):106-9. PubMed ID: 12554889
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma.
Kostikas K; Gaga M; Papatheodorou G; Karamanis T; Orphanidou D; Loukides S
Chest; 2005 May; 127(5):1553-9. PubMed ID: 15888827
[TBL] [Abstract][Full Text] [Related]
5. Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients.
Kanazawa H; Yoshikawa T; Hirata K; Yoshikawa J
Chest; 2004 May; 125(5):1700-5. PubMed ID: 15136379
[TBL] [Abstract][Full Text] [Related]
6. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
7. Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD.
Beeh KM; Beier J; Koppenhoefer N; Buhl R
Chest; 2004 Oct; 126(4):1116-22. PubMed ID: 15486372
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in expired breath condensate of patients with COPD.
Kostikas K; Papatheodorou G; Psathakis K; Panagou P; Loukides S
Chest; 2003 Oct; 124(4):1373-80. PubMed ID: 14555568
[TBL] [Abstract][Full Text] [Related]
9. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.
Antus B; Harnasi G; Drozdovszky O; Barta I
Respirology; 2014 Jan; 19(1):74-9. PubMed ID: 23834671
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating thrombomodulin levels with exercise in patients with chronic obstructive pulmonary disease.
Kanazawa H; Asai K; Nomura S
Respirology; 2007 Sep; 12(5):670-4. PubMed ID: 17875054
[TBL] [Abstract][Full Text] [Related]
11. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
Tsoumakidou M; Papadopouli E; Tzanakis N; Siafakas NM
Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
Kawamoto T; Kanazawa H; Tochino Y; Kawaguchi T
Respir Med; 2018 Aug; 141():159-164. PubMed ID: 30053962
[TBL] [Abstract][Full Text] [Related]
13. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.
Kanazawa H; Asai K; Hirata K; Yoshikawa J
Am J Med; 2003 Apr; 114(5):354-8. PubMed ID: 12714123
[TBL] [Abstract][Full Text] [Related]
14. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
[TBL] [Abstract][Full Text] [Related]
15. Increased oxidative stress and altered levels of nitric oxide and peroxynitrite in Tunisian patients with chronic obstructive pulmonary disease: correlation with disease severity and airflow obstruction.
ben Anes A; Fetoui H; Bchir S; ben Nasr H; Chahdoura H; Chabchoub E; Yacoub S; Garrouch A; Benzarti M; Tabka Z; Chahed K
Biol Trace Elem Res; 2014 Oct; 161(1):20-31. PubMed ID: 25074430
[TBL] [Abstract][Full Text] [Related]
16. Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma.
Kanazawa H; Eguchi Y; Nomura N; Yoshikawa J
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):266-71. PubMed ID: 16200818
[TBL] [Abstract][Full Text] [Related]
17. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine.
Osoata GO; Hanazawa T; Brindicci C; Ito M; Barnes PJ; Kharitonov S; Ito K
Chest; 2009 Jun; 135(6):1513-1520. PubMed ID: 19188555
[TBL] [Abstract][Full Text] [Related]
19. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
20. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
Zhang XJ; He SH; Xie H; Wei JF; Liu CT
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
